CAMS Oxford Institute Group Leader and Career Development Fellow, Adán Pinto-Fernández, has been awarded a highly competitive 2-year project grant by Boehringer Ingelheim through their Open Innovation Portal initiative, opnMe. Out of 31 submissions from 12 countries, Adán's proposal was selected to address Boehringer Ingelheim’s challenge on the "stabilization of protein-protein interactions to target cancer cells."
The project, led by Adán Pinto-Fernández, will focus on enhancing a specific protein-protein interaction with significant therapeutic potential in the field of immuno-oncology. By collaborating closely with a dedicated team at Boehringer Ingelheim, Adán's group aims to contribute to the development of innovative cancer therapies that leverage the body's immune response.
"We are honoured to have our proposal chosen from such a competitive field and to work alongside the outstanding scientists from a prestigious institution like Boehringer Ingelheim. This grant will enable us to delve deeper into the mechanisms of protein-protein interactions and explore new avenues for cancer treatment." – Adán Pinto-Fernández.
This collaboration with Boehringer Ingelheim will bring together the expertise of both teams, fostering an environment of innovation and shared knowledge. This partnership is expected to yield insights that could pave the way for novel treatments in immuno-oncology.
For more information on Adán Pinto-Fernández's research at COI, please visit the Pinto-Fernández Group Page.